PWMG
ACAD icon

Private Wealth Management Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Private Wealth Management Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.85K Hold
218
– – ﹤0.01% 784
2025
Q4 		$5.82K Hold
218
– – ﹤0.01% 715
2025
Q3 		$4.65K Hold
218
– – ﹤0.01% 817
2025
Q2 		$4.7K Sell
218
-72
-25% -$1.34K ﹤0.01% 777
2025
Q1 		$4.82K Hold
290
– – ﹤0.01% 741
2024
Q4 		$5.32K Buy
+290
New +$4.68K ﹤0.01% 717
2024
Q3 		– Sell
-63
Closed -$1.02K – 1500
2024
Q2 		$1.02K Buy
63
+20
+47% +$323 ﹤0.01% 1283
2024
Q1 		$796 Hold
43
– – ﹤0.01% 1339
2023
Q4 		$1.35K Buy
+43
New +$1.03K ﹤0.01% 1155

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return